A new taxonomy for describing and defining adherence to medications

British Journal of Clinical Pharmacology

Volumn 73, Issue 5, 2012, Pages 691-705

  Vrijens, Bernard ^a,b   De Geest, Sabina ^c,d   Hughes, Dyfrig A ^e   Przemyslaw, Kardas ^f   Demonceau, Jenny ^a   Ruppar, Todd ^c,g   Dobbels, Fabienne ^c   Fargher, Emily ^e   Morrison, Valerie ^e   Lewek, Pawel ^f   Matyjaszczyk, Michal ^f   Mshelia, Comfort ^h   Clyne, Wendy ^h   Aronson, Jeffrey K ⁱ   Urquhart, J ^a,j  

^a AARDEX Group   (Switzerland)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF BASEL   (Switzerland)

^e BANGOR UNIVERSITY   (United Kingdom)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g UNIVERSITY OF MISSOURI   (United States)

^h KEELE UNIVERSITY   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Concordance; Medication adherence; Patient compliance; Persistence; Taxonomy; Terminology

Indexed keywords

ARTICLE; CINAHL; COCHRANE LIBRARY; EMBASE; HUMAN; MEDICAL RESEARCH; MEDICAL SOCIETY; MEDLINE; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCINFO; QUANTITATIVE ANALYSIS; SYSTEMATIC REVIEW; TAXONOMY;

DATABASES, FACTUAL; DISEASE MANAGEMENT; DRUG MONITORING; HUMANS; MEDICATION ADHERENCE; PATIENT CARE MANAGEMENT; PHARMACEUTICAL PREPARATIONS;

EID: 84859418551     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04167.x     Document Type: Article

References (146)

1. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353: 487-97.
2. Rand CS. Measuring adherence with therapy for chronic diseases: implications for the treatment of heterozygous familial hypercholesterolemia. Am J Cardiol 1993; 72: 68D-74D.
3. World Health Organization. Adherence to Long-Term Therapies: Evidence for Action. Geneva: WHO, 2003.
4. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin 2009; 59: 56-66.
5. Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am 2008; 43: 133-53.
6. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130: (1 Suppl.): 65S-72S.
7. Rapoff MA. Management of adherence and chronic rheumatic disease in children and adolescents. Best Pract Res Clin Rheumatol 2006; 20: 301-14.
8. van der Wal MH, Jaarsma T. Adherence in heart failure in the elderly: problem and possible solutions. Int J Cardiol 2008; 125: 203-8.
9. Loghman-Adham M. Medication noncompliance in patients with chronic disease: issues in dialysis and renal transplantation. Am J Manag Care 2003; 9: 155-71.
10. Schwartz GF, Quigley HA. Adherence and persistence with glaucoma therapy. Surv Ophthalmol 2008; 53 (Suppl. 1): S57-68.
11. Schwartz GF. Compliance and persistency in glaucoma follow-up treatment. Curr Opin Ophthalmol 2005; 16: 114-21.
12. Cramer JA, Benedict A, Muszbek N, Keskinaslan A, Khan ZM. The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. Int J Clin Pract 2008; 62: 76-87.
13. Vrijens B, Urquhart J. Patient adherence to prescribed antimicrobial drug dosing regimens. J Antimicrob Chemother 2005; 55: 616-27.
14. McLean W. Medication adherence initiatives - Part I. Can Pharm J 2007; 140: 254-61.
15. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657-65.
16. Apt L, Barrett AB. Patient compliance vs. cooperation. Arch Ophthalmol 1987; 105: 315.
17. Lehane E, McCarthy G. Medication non-adherence - exploring the conceptual mire. Int J Nurs Pract 2009; 15: 25-31.
18. Romano PE. Romano semantics: compliance is a better term than cooperation. Arch Ophthalmol 1988; 106: 450.
19. Romano PE. Semantics: compliance is better term than cooperation. Arch Ophthalmol 1987; 105: 314-5.
20. Andrade SE, Kahler KH, Frech F, Chan KA. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 2006; 15: 565-74.
21. Bissonnette JM. Adherence: a concept analysis. J Adv Nurs 2008; 63: 634-43.
22. Dodds F, Rebair-Brown A, Parsons S. A systematic review of randomized controlled trials that attempt to identify interventions that improve patient compliance with prescribed antipsychotic medication. Clin Effect Nurs 2000; 4: 47-53.
23. Friberg F, Scherman MH. Can a teaching and learning perspective deepen understanding of the concept of compliance? A theoretical discussion. Scand J Caring Sci 2005; 19: 274-9.
24. German PS. Compliance and chronic disease. Hypertension 1988; 11 (3 Pt 2): II56-60.
25. Gold DT. Medication adherence: a challenge for patients with postmenopausal osteoporosis and other chronic illnesses. J Manag Care Pharm 2006; 12 (6 Suppl. A): S20-5.
26. Hearnshaw H, Lindenmeyer A. What do we mean by adherence to treatment and advice for living with diabetes? A review of the literature on definitions and measurements. Diabet Med 2006; 23: 720-8.
27. Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006; 17: 136-42.
28. Karoly P. Enlarging the scope of the compliance construct: toward developmental and motivational relevance. In: Developmental Aspects of Health Compliance Behavior, eds Kranegor NA, Epstein LH, Johnson SB, Yaffe SJ, Hillsdale NJ: Lawrance Erlbaum Associates, Inc., 1993; 11-27.
29. Kettler LJ, Sawyer SM, Winefield HR, Greville HW. Determinants of adherence in adults with cystic fibrosis. Thorax 2002; 57: 459-64.
30. Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther 2005; 22: 313-56.
31. Kunze M. Psychological background of noncompliance in old age. Gerontology 1982; 28 (Suppl. 1): 116-22.
32. La Greca A, Schuman WB. Adherence to prescribed medical regimens. In: Handbook of Pediatric Psychology, 2nd edn, ed. Roberts MC. New York: Guilford Press, 1995; 55-83.
33. Lahdenperä T, Kyngäs H. Compliance and its evaluation in patients with hypertension. J Clin Nurs 2000; 9: 826-33.
34. Linden M. Definition of compliance. Int J Clin Pharmacol Ther Toxicol 1981; 19: 86-90.
35. Snowden A. Medication management in older adults: a critique of concordance. Br J Nurs 2008; 17: 114-9.
36. Velligan DI, Lam YW, Glahn DC, Barrett JA, Maples NJ, Ereshefsky L, Miller AL. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 2006; 32: 724-42.
37. Wride N, Finch T, Rapley T, Moreira T, May C, Fraser S. What's in a name? Medication terms: what they mean and when to use them. Br J Ophthalmol 2007; 91: 1422-4.
38. NICE clinical guidelines. Available at (last accessed 13 February 2009).
39. Sawyer SM, Aroni RA. Sticky issue of adherence. J Paediatr Child Health 2003; 39: 2-5.
40. Tsoneva J, Shaw J. Understanding patients' beliefs and goals in medicine-taking. Prof Nurse 2004; 19: 466-8.
41. Hughes CM. Medication non-adherence in the elderly: how big is the problem? Drugs Aging 2004; 21: 793-811.
42. Johnson SB, Carlson DN. Medical regimen adherence: concepts, assessments, and interventions. In: Handbook of Clinical Health Psychology, Vol 2. Disorders of Behavior and Health, ed. Racsynski JM. Washington, DC: American Psychological Association, 2002; 329-54.
43. Katz Y, Goldberg M. Non-adherence, non-compliance or non-concordance in asthma: patients not following the medical regimen. Isr Med Assoc J 2007; 9: 389-90.
44. Keeling A, Utz SW, Shuster GF III, Boyle A. Noncompliance revisited: a disciplinary perspective of a nursing diagnosis. Nurs Diagn 1993; 4: 91-8.
45. Whitley GG. Noncompliance: an update. Issues Ment Health Nurs 1991; 12: 229-38.
46. Aronson JK. Time to abandon the term 'Patient concordance. Br J Clin Pharmacol 2007; 64: 711-13.
47. Barber N. Should we consider non-compliance a medical error? Qual Saf Health Care 2002; 11: 81-4.
48. Bell JS, Airaksinen MS, Lyles A, Chen TF, Aslani P. Concordance is not synonymous with compliance or adherence. Br J Clin Pharmacol 2007; 64: 710-1.
49. de Almeida Neto AC, Aslani P. Medicines concordance in clinical practice. Br J Clin Pharmacol 2008; 66: 453-4.
50. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD000011.
51. Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008; (2): CD000011.
52. Horne R, Weinman J, Barber N, Elliott R, Morgan M. Concordance, adherence and compliance in medicine - taking. 2005. Report for the National Co-ordinating Centre for NHS Service Delivery and Organisation R&D.
53. Metcalfe R. Compliance, adherence, concordance- What's in the NAME? Practical Neurology 2005; 5: 192-3.
54. Rossi S. Compliance or concordance? Australian Prescriber 2000; 23: 105.
55. Stevenson FA. Concordance: what is the relevance for pharmacists? Int J Pharm Pract 2001; 9: 67-70.
56. Treharne GJ, Lyons AC, Hale ED, Douglas KM, Kitas GD. 'Compliance' is futile but is 'concordance' between rheumatology patients and health professionals attainable? Rheumatology (Oxford) 2006; 45: 1-5.
57. Vermeire E, Hearnshaw H, Van RP, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001; 26: 331-42.
58. Pitkin J. Compliance with estrogen replacement therapy: current issues. Climacteric 2002; 5 (Suppl. 2): 12-9.
59. Cals JW. Comment on: the higher the number of daily doses of antibiotic treatment in lower respiratory tract infection the worse the compliance. J Antimicrob Chemother 2009; 63: 1083-4.
60. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med 2000; 132: 926-30.
61. Lerner BH. From careless consumptives to recalcitrant patients: the historical construction of noncompliance. Soc Sci Med 1997; 45: 1423-31.
62. Trostle JA. Medical compliance as an ideology. Soc Sci Med 1988; 27: 1299-308.
63. Vermeire E, Wens J, Van RP, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; (2): CD003638.
64. Sackett DL, Haynes RB. Compliance with Therapeutic Regimens. Baltimore, MD: The Johns Hopkins University Press, 1976.
65. Moulding T. Preliminary study of the pill calendar as a method of improving the self-administration of drugs. Am Rev Respir Dis 1961; 84: 284-7.
66. Blackwell B. Compliance. Psychother Psychosom 1992; 58: 161-9.
67. Blackwell B. Compliance. In: Handbook of Psychosomatic Medicine. 1st edn., eds Fava GA, Freyberger H. Madison, CT: International Universities Press, 1998; 625-38.
68. Lee IA, Maibach HI. Pharmionics in dermatology: a review of topical medication adherence. Am J Clin Dermatol 2006; 7: 231-6.
69. Urquhart J. Pharmionics: research on what patients do with prescription drugs. Pharmacoepidemiol Drug Saf 2004; 13: 587-90.
70. Urquhart J, Vrijens B. New findings about patient adherence to prescribed drug dosing regimens: an introduction to pharmionics. Eur J Hosp Pharm Sci 2005; 11: 103-6.
71. Blackwell B. From compliance to alliance. A quarter century of research. Neth J Med 1996; 48: 140-9.
72. Hess LM. Terminology used in medication adherence research must reflect current models of health care. Value Health 2009; 12: 630.
73. Lask B. Compliance, adherence, concordance. Br J Psychiatry 1998; 173: 271-2.
74. Myers LB, Midence K. Concepts and issues in adherence. In: Adherence to Treatment in Medical Conditions, eds Myers LB, Midence K. Amsterdam: Harwood Academic Publishers, 1998; 1-24.
75. O'Brien MK, Petrie K, Raeburn J. Adherence to medication regimens: updating a complex medical issue. Med Care Rev 1992; 49: 435-54.
76. Price PE, ed. Education, psychology and 'compliance'. Diabetes Metab Res Rev 2008; 24 (Suppl. 1): S101-5.
77. Tilson HH. Adherence or compliance? Changes in terminology. Ann Pharmacother 2004; 38: 161-2.
78. Ward-Collins D. 'Noncompliant.' Isn't there a better way to say it? Am J Nurs 1998; 98: 26-31.
79. Bernardini J. Ethical issues of compliance/adherence in the treatment of hypertension. Adv Chronic Kidney Dis 2004; 11: 222-7.
80. Levensky ER. Nonadherence to treatment. In: Practioner's Guide to Evidence-Based Psychotherapy, ed. Fisher JE. New York: Springer Science + Business Media, 2006; 442-52.
81. Lutfey KE, Wishner WJ. Beyond 'compliance' is 'adherence'. Improving the prospect of diabetes care. Diabetes Care 1999; 22: 635-9.
82. Brockie J. Compliance or concordance? J Br Menopause Soc 2000; 6: 23-6.
83. Royal Pharmaceutical Society of Great Britain. From Compliance to Concordance: Towards Shared Goals in Medicine Taking. London: RPS, 1997.
84. Bokhour BG, Cohn ES, Cortes DE, Yinusa-Nyahkoon LS, Hook JM, Smith LA, Rand CS, Lieu TA. Patterns of concordance and non-concordance with clinician recommendations and parents' explanatory models in children with asthma. Patient Educ Couns 2008; 70: 376-85.
85. Chatterjee JS. From compliance to concordance in diabetes. J Med Ethics 2006; 32: 507-10.
86. Dickinson D, Wilkie P, Harris M. Taking medicines: concordance is not compliance. BMJ 1999; 319: 787.
87. Mandal A. The concept of concordance and its relation to leg ulcer management. J Wound Care 2006; 15: 339-41.
88. Marinker M. The current status of compliance. Eur Respir Rev 1998; 8: 235-38.
89. Mullen PD. Compliance becomes concordance. BMJ 1997; 314: 691-2.
90. Rier DA, Indyk D. Flexible rigidity: supporting HIV treatment adherence in a rapidly-changing treatment environment. Soc Work Health Care 2006; 42: 133-50.
91. Segal JZ. 'Compliance' to 'concordance': a critical view. J Med Humanit 2007; 28: 81-96.
92. Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95: 1085-90.
93. Elliott R. Non-adherence to medicines: not solved but solvable. J Health Serv Res Policy 2009; 14: 58-61.
94. Elliott RA, Shinogle JA, Peele P, Bhosle M, Hughes DA. Understanding medication compliance and persistence from an economics perspective. Value Health 2008; 11: 600-10.
95. Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud 2007; 44: 1468-77.
96. Mitchell AJ. Adherence behaviour with psychotropic medication is a form of self-medication. Med Hypotheses 2007; 68: 12-21.
97. Nordqvist O, Sodergard B, Tully MP, Sonnerborg A, Lindblad AK. Assessing and achieving readiness to initiate HIV medication. Patient Educ Couns 2006; 62: 21-30.
98. Shearer HM, Evans DR. Adherence to health care. In: Handbook of Cultural Health Psychology, eds Kazarian SS, Evans DR. San Diego, CA: US Academic Press, 2001; 113-38.
99. Stevenson FA. Concordance. Soc Theory Health 2004; 2: 184-93.
100. Chisholm-Burns MA, Spivey CA. Pharmacoadherence: a new term for a significant problem. Am J Health Syst Pharm 2008; 65: 661-7.
101. Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiatr Scand 1999; 100: 167-75.
102. Kyngas H, Duffy ME, Kroll T. Conceptual analysis of compliance. J Clin Nurs 2000; 9: 5-12.
103. Leventhal H, Lambert JF, Diefenbach M, Leventhal EA. From compliance to social-self-regulation: models of the compliance process. In: Treatment Compliance and the Therapeutic Alliance, ed. Blackwell B. Amsterdam: Harwood Academic Publishers, 1997; 17-33.
104. Madden BP. The hybrid model for concept development: its value for the study of therapeutic alliance. ANS Adv Nurs Sci 1990; 12: 75-87.
105. Weiden PJ, Rao N. Teaching medication compliance to psychiatric residents: placing an orphan topic into a training curriculum. Acad Psychiatry 2005; 29: 203-10.
106. Bond C. Concordance- Is it a synonym for compliance or a paradigm shift? Pharm J 2003; 271: 496-7.
107. Gray R, Wykes T, Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. J Psychiatr Ment Health Nurs 2002; 9: 277-84.
108. Hobden A. Concordance: a widely used term, but what does it mean? Br J Community Nurs 2006; 11: 257-60.
109. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-8.
110. La Greca AM. Issues in adherence with pediatric regimens. J Pediatr Psychol 1990; 15: 423-36.
111. Fincham JE, Wertheimer AI. Using the health belief model to predict initial drug therapy defaulting. Soc Sci Med 1985; 20: 101-5.
112. Aronson JK. Compliance, concordance, adherence. Br J Clin Pharmacol 2007; 63: 383-4.
113. Donovan JL, Blake DR. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992; 34: 507-13.
114. Kontz MM. Compliance redefined and implications for home care. Holist Nurs Pract 1989; 3: 54-64.
115. Anthonisen NR. Persistence and compliance. Can Respir J 2004; 11: 13-4.
116. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens 2006; 19: 1190-6.
117. Chen CH, Wu JR, Yen M, Chen ZC. A model of medication-taking behavior in elderly individuals with chronic disease. J Cardiovasc Nurs 2007; 22: 359-65.
118. Colom F, Vieta E, Tacchi MJ, Sanchez-Moreno J, Scott J. Identifying and improving non-adherence in bipolar disorders. Bipolar Disord 2005; 7 (Suppl. 5): 24-31.
119. Cramer JA, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA, Wong PK. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-7.
120. Ekedahl A, Oskarsson V, Sundberg B, Gustafsson V, Lundberg T, Gullberg B. Impact of postal and telephone reminders on pick-up rates of unclaimed e-prescriptions. Pharm World Sci 2008; 30: 503-8.
121. Hudson M, Rahme E, Richard H, Pilote L. Comparison of measures of medication persistency using a prescription drug database. Am Heart J 2007; 153: 59-65.
122. Hughes D, Cowell W, Koncz T, Cramer J. Methods for integrating medication compliance and persistence in pharmacoeconomic evaluations. Value Health 2007; 10: 498-509.
123. Lafleur J, Oderda GM. Methods to measure patient compliance with medication regimens. J Pain Palliat Care Pharmacother 2004; 18: 81-7.
124. Lopatriello S, Berto P, Cramer J, Bustacchini S, Ruffo P. Different aspects of adherence to antihypertensive treatments. Expert Rev Pharmacoecon Outcomes Res 2004; 4: 317-33.
125. Rachid A. Do patients cash prescriptions? Br Med J (Clin Res Ed) 1982; 284: 24-6.
126. Sodergard B, Hofer S, Halvarsson M, Sonnerborg A, Tully MP, Lindblad AK. A structural equation modeling approach to the concepts of adherence and readiness in antiretroviral treatment. Patient Educ Couns 2007; 67: 108-16.
127. Strom O, Borgstrom F, Kanis JA, Jonsson B. Incorporating adherence into health economic modelling of osteoporosis. Osteoporos Int 2009; 20: 23-34.
128. Urquhart J, Vrijens B. Taxonomy of patient compliance-related events in drug trials. Snowbird conference on causal inference 2001. 2001.
129. Kemppainen JK, Levine R, Buffum M, Holzemer W, Finley P, Jensen P. Antiretroviral adherence in persons with HIV/AIDS and severe mental illness. J Nerv Ment Dis 2004; 192: 395-404.
130. Kothawala P, Badamgarav E, Ryu S, Miller RM, Halbert RJ. Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc 2007; 82: 1493-501.
131. Dunbar J. Adherence measures and their utility. Control Clin Trials 1984; 5: (4 Suppl.): 515-21.
132. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-7.
133. Fine RN, Becker Y, De GS, Eisen H, Ettenger R, Evans R, Rudow DL, McKey D, Neu A, Nevins T, Reyes J, Wray J, Dobbels F. Nonadherence consensus conference summary report. Am J Transplant 2009; 9: 35-41.
134. Urquhart J. Role of patient compliance in clinical pharmacokinetics. A review of recent research. Clin Pharmacokinet 1994; 27: 202-15.
135. Flexner C. Pharmacoecology: a new name for an old science. Clin Pharmacol Ther 2008; 83: 375-9.
136. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997; 43: 27-39.
137. Evangelista LS. Compliance: a concept analysis. Nurs Forum 1999; 34: 5-11.
138. Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006; 28: 1411-24.
139. Cleemput I, Kesteloot K, DeGeest S. A review of the literature on the economics of noncompliance. Room for methodological improvement. Health Policy 2002; 59: 65-94.
140. Halpern MT, Khan ZM, Schmier JK, Burnier M, Caro JJ, Cramer J, Daley WL, Gurwitz J, Hollenberg NK. Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension 2006; 47: 1039-48.
141. Peterson AM, Nau DP, Cramer JA, Benner J, Gwadry-Sridhar F, Nichol M. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10: 3-12.
142. Sikka R, Xia F, Aubert RE. Estimating medication persistency using administrative claims data. Am J Manag Care 2005; 11: 449-57.
143. Haynes RB, Taylor DW, Sackett DL. Compliance in Health Care. Baltimore, MD: Johns Hopkins University Press, 1979.
144. Dracup KA, Meleis AI. Compliance: an interactionist approach. Nurs Res 1982; 31: 31-6.
145. Meichenbaum D, Turk DC. Facilitating Treatment Adherence: A Practioner's Guidebook. New York: Plenum, 1987.
146. Balkrishnan R. The importance of medication adherence in improving chronic-disease related outcomes: what we know and what we need to further know. Med Care 2005; 43: 517-20.